Allarity Therapeutics, Inc.
ALLR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001860657
No open-market purchases or sales by Allarity Therapeutics, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Allarity Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 11
- +1 vs. Q2 2025
- Shares held
- 1.03M
- +838.1K (+429.6%) vs. Q2 2025
- Total value
- $1.63M
- +$1.44M (+728.5%) vs. Q2 2025
- New holders
- 7
- 1 more added
- Sold out
- 6
- 1 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALLR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $1.65M |
| Q1 2026 | 14 | $1.04M |
| Q4 2025 | 16 | $1.40M |
| Q3 2025 | 11 | $1.63M |
| Q2 2025 | 10 | $197.0K |
| Q1 2025 | 9 | $86.5K |
| Q4 2024 | 6 | $122.3K |
| Q3 2024 | 4 | $46.2K |
| Q2 2024 | 9 | $107.8K |
| Q1 2024 | 4 | $11.7K |
| Q4 2023 | 4 | $31.8K |
| Q3 2023 | 7 | $515.6K |
| Q2 2023 | 4 | $33.3K |
| Q1 2023 | 6 | $4.05K |
| Q4 2022 | 10 | $42.0K |
| Q3 2022 | 10 | $181.0K |
| Q2 2022 | 10 | $304.0K |
| Q1 2022 | 10 | $694.0K |
| Q4 2021 | 3 | $270.0K |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Allarity Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Private Advisor Group, LLC | 278,949 | $440.7K | 0.00% | +278,949 | New |
| Vanguard Group Inc | 246,708 | $389.8K | 0.00% | +246,708 | New |
| Geode Capital Management, LLC | 151,927 | $240.0K | 0.00% | +101,277+200.0% | Added |
| State Street Corp | 137,600 | $217.4K | 0.00% | +137,600 | New |
| Citadel Advisors LLC | 94,142 | $148.7K | 0.00% | +94,142 | New |
| Renaissance Technologies LLC | 66,186 | $104.6K | 0.00% | +66,186 | New |
| Northern Trust Corp | 43,626 | $68.9K | 0.00% | +43,626 | New |
| Two Sigma Investments, LP | 13,910 | $22.0K | 0.00% | +13,910 | New |
| Bank of America Corp | 134 | $212 | 0.00% | −4−2.9% | Reduced |
| Advisor Group Holdings, Inc. | 7 | $10 | 0.00% | 00.0% | Unchanged |
| Danske Bank A/S | 1 | $2 | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 0 | $0 | 0.00% | −50,950−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −47,984−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −26,365−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −14,450−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −3,073−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1,472−100.0% | Sold out |